When to close iatrogenic atrial septal defect after percutaneous edge to edge repair of mitral valve regurgitation

Cardiovasc Revasc Med. 2016 Sep;17(6):421-3. doi: 10.1016/j.carrev.2016.04.005. Epub 2016 Apr 25.

Abstract

Transseptal puncture is increasingly utilized in electrophysiology and interventional cardiology. With a wide range of therapeutic indications, incidence of iatrogenic atrial septal defect (iASD) is likely to increase. However, the clinical and hemodynamic significance of iatrogenic atrial septal defect is not clear. We report a case of an 88year old woman with prior transcatheter aortic valve implantation and symptomatic severe degenerative mitral regurgitation. She developed persistent hypoxemia following MitraClip(®) procedure, requiring closure of iASD resulting in immediate recovery of hemodynamics. In here, we discuss the hemodynamic changes following percutaneous mitral valve repair and review the evidence supporting the closure of iatrogenic atrial septal defects.

Keywords: Iatrogenic atrial septal defect; Shunting; Trans septal puncture; Transesophageal echocardiography.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Atrial Septum / diagnostic imaging
  • Atrial Septum / injuries*
  • Atrial Septum / physiopathology
  • Cardiac Catheterization / adverse effects*
  • Cardiac Catheterization / instrumentation
  • Echocardiography, Doppler, Color
  • Echocardiography, Transesophageal
  • Female
  • Heart Injuries / diagnostic imaging
  • Heart Injuries / etiology
  • Heart Injuries / physiopathology
  • Heart Injuries / therapy*
  • Hemodynamics
  • Humans
  • Iatrogenic Disease*
  • Mitral Valve Insufficiency / diagnostic imaging
  • Mitral Valve Insufficiency / physiopathology
  • Mitral Valve Insufficiency / therapy*
  • Mitral Valve* / diagnostic imaging
  • Mitral Valve* / physiopathology
  • Recovery of Function
  • Retreatment
  • Septal Occluder Device
  • Treatment Outcome